Total Payments
$1,880
2024 Payments
$108.15
Companies
26
Transactions
39
Medicare Patients
2,311
Medicare Billing
$360,747
Payment Breakdown by Category
Food & Beverage$1,550 (82.4%)
Education$330.09 (17.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,550 | 35 | 82.4% |
| Education | $330.09 | 4 | 17.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $341.08 | 4 | $0 (2024) |
| GENZYME CORPORATION | $238.40 | 3 | $0 (2019) |
| Augmenix, Inc. | $206.98 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $137.19 | 2 | $0 (2018) |
| Varian Medical Systems, Inc. | $133.28 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $107.71 | 2 | $0 (2022) |
| Covidien LP | $102.49 | 1 | $0 (2017) |
| Clovis Oncology, Inc. | $84.99 | 1 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $77.06 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108.15 | 2 | Astellas Pharma US Inc ($85.05) |
| 2023 | $32.67 | 2 | Boston Scientific Corporation ($18.67) |
| 2022 | $288.03 | 5 | Astellas Pharma US Inc ($160.05) |
| 2021 | $37.40 | 1 | Blue Earth Diagnostics Limited ($37.40) |
| 2020 | $84.99 | 1 | Clovis Oncology, Inc. ($84.99) |
| 2019 | $360.54 | 6 | GENZYME CORPORATION ($238.40) |
| 2018 | $479.54 | 16 | Varian Medical Systems, Inc. ($120.88) |
| 2017 | $488.72 | 6 | E.R. Squibb & Sons, L.L.C. ($125.00) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 01/29/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/29/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 10/05/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $75.00 | General |
| 04/21/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 03/30/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $91.66 | General |
| Category: Oncology | ||||||
| 01/17/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 01/13/2022 | Palette Life Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.73 | General |
| 10/24/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $37.40 | General |
| Category: Diagnostic Imaging | ||||||
| 11/10/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Oncology | ||||||
| 11/05/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $95.98 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2019 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 03/18/2019 | Varian Medical Systems, Inc. | Radiation Oncology (Device) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Devices | ||||||
| 03/06/2019 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Oncology | ||||||
| 10/22/2018 | Varian Medical Systems, Inc. | TrueBeam (Device) | Food and Beverage | In-kind items and services | $102.32 | General |
| Category: Devices | ||||||
| 10/17/2018 | Regeneron Healthcare Solutions, Inc. | LIBTAYO CEMIPLIMAB-RWLC INJECTION (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Oncology | ||||||
| 10/11/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Oncology | ||||||
| 10/10/2018 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $13.48 | General |
| 09/28/2018 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $12.96 | General |
| 09/13/2018 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diagnostic Imaging | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 512 | 1,484 | $332,611 | $84,174 |
| 2022 | 18 | 637 | 1,478 | $361,619 | $91,870 |
| 2021 | 17 | 540 | 1,332 | $317,860 | $84,366 |
| 2020 | 17 | 622 | 1,650 | $379,028 | $100,337 |
Total Patients
2,311
Total Services
5,944
Medicare Billing
$360,747
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 44 | 171 | $92,853 | $23,921 | 25.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 63 | 504 | $65,520 | $16,765 | 25.6% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 25 | 25 | $30,275 | $7,864 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 104 | 137 | $26,304 | $4,766 | 18.1% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 25 | 25 | $16,250 | $4,219 | 26.0% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 21 | 251 | $13,303 | $3,842 | 28.9% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 40 | 76 | $13,300 | $3,429 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $12,246 | $3,254 | 26.6% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 26 | 26 | $12,532 | $3,163 | 25.2% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 16 | 18 | $11,700 | $3,028 | 25.9% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 38 | 120 | $11,400 | $2,929 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 20 | $7,600 | $2,016 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 26 | $7,124 | $1,727 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,696 | $1,581 | 27.8% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 14 | 14 | $3,318 | $870.52 | 26.2% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 16 | 29 | $3,190 | $799.12 | 25.1% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 53 | 155 | $84,165 | $21,764 | 25.9% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 52 | 396 | $51,480 | $13,264 | 25.8% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 33 | 33 | $39,963 | $10,092 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 114 | 154 | $29,568 | $5,935 | 20.1% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 33 | 34 | $22,100 | $5,568 | 25.2% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 43 | 43 | $20,726 | $5,121 | 24.7% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 53 | 105 | $18,375 | $4,759 | 25.9% |
| 77300 | Calculation of radiation therapy dose | Facility | 2022 | 48 | 178 | $16,910 | $4,339 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $11,036 | $3,148 | 28.5% |
About Dr. David Hornback, MD
Dr. David Hornback, MD is a Radiation Oncology healthcare provider based in South Bend, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790770964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hornback, MD has received a total of $1,880 in payments from pharmaceutical and medical device companies, with $108.15 received in 2024. These payments were reported across 39 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,550).
As a Medicare-enrolled provider, Hornback has provided services to 2,311 Medicare beneficiaries, totaling 5,944 services with total Medicare billing of $360,747. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location South Bend, IN
- Active Since 09/14/2005
- Last Updated 07/01/2021
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1790770964
Products in Payments
- SpaceOAR (Device) $206.98
- JEVTANA (Drug) $138.40
- OPDIVO (Biological) $125.00
- TAGRISSO (Drug) $124.99
- Beacon (Device) $102.49
- TrueBeam (Device) $102.32
- LIBTAYO (Drug) $100.00
- XTANDI (Drug) $95.98
- ERLEADA (Drug) $91.66
- Rubraca (Drug) $84.99
- DARZALEX (Biological) $77.06
- Axumin (Drug) $54.37
- Xofigo (Drug) $29.77
- Optune (Device) $26.96
- Nerlynx (Drug) $25.74
- PYLARIFY (Drug) $23.10
- SpaceOAR VUE System - 10mL (Device) $18.67
- Rapid Arc (Device) $18.56
- Gelclair (Device) $18.29
- Prolaris (Device) $17.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.